Wolverine Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Wolverine Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,680	Closed	-$306K	–	2224
2022 Q4	$219K	Sell	17,680 -8,310	-32%	-$118K	﹤0.01%	1133
2022 Q3	$362K	Buy	+25,990	New	+$419K	﹤0.01%	1119
2021 Q3	–	Sell	-112,645	Closed	-$1.8M	–	2473
2021 Q2	$2.25M	Buy	+112,645	New	+$2.23M	0.02%	417
2021 Q1	–	Sell	-2,071	Closed	-$57.7K	–	2340
2020 Q4	$51K	Buy	+2,071	New	+$68.6K	﹤0.01%	1330
2020 Q3	–	Sell	-312	Closed	-$14.3K	–	1837
2020 Q2	$14K	Buy	+312	New	+$24.1K	﹤0.01%	1399
2018 Q1	–	Sell	-32,807	Closed	-$1.92M	–	1742
2017 Q4	$1.92M	Buy	+32,807	New	+$2.07M	0.02%	528

Wolverine Asset Management's ICPT Position: Q1 2023 in Review

Wolverine Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 17,680 shares — an estimated $306K sold.

Wolverine Asset Management first reported a position in ICPT in Q4 2017 and held it in 6 quarters. The position peaked at $2.25M in Q2 2021. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

Wolverine Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Wolverine Asset Management sold 17,680 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $306K.
Wolverine Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
Wolverine Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $2.25M in Q2 2021.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.